How much funding has Pixium Vision raised?

Pixium Vision has raised $19.3M in total funding, most recently a Series A round.

Who are Pixium Vision's investors?

Pixium Vision's investors include Sofinnova Partners, Bpifrance.

When was Pixium Vision founded?

Pixium Vision was founded in 2011.

Where is Pixium Vision headquartered?

Pixium Vision is headquartered in Paris, France.

What industry is Pixium Vision in?

Pixium Vision operates in Biotech, Healthcare.

How many employees does Pixium Vision have?

Pixium Vision has 11-50 employees.

Pixium Vision

IPO

Paris, France · Founded 2011 · $19.3M raised

Biotech

Healthcare

Headquarters: Paris
Employees: 11–50
Founded: 2011
Business Model: B2B

Website: pixium-vision.com
Total Funding: $19.3M
Last Round: $19.3M Series AJul 2023
Rounds: 2

About

Pixium Vision was a French medical device company founded in 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie in Paris. The company developed bionic vision systems — most notably the PRIMA subretinal implant — designed to restore partial sight in patients blinded by late-stage retinal degenerative diseases such as dry age-related macular degeneration. Pixium conducted clinical trials in Europe across multiple countries. In 2024, the company went bankrupt and its assets, including ongoing PRIMA clinical trials, were acquired by Science Corporation.

Summary

Pixium Vision is a Biotech company based in Paris, France, founded in 2011. It has raised $19.3M in total across 2 rounds, most recently a $19.3M Series A round in Jul 2023. Investors include Sofinnova Partners and Bpifrance.